Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
101.50
+0.50 (0.49%)
Aug 12, 2025, 1:30 PM CST

Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 12.45 billion as of August 11, 2025. Its market cap has decreased by -18.66% in one year.

Market Cap
12.45B
Enterprise Value
10.55B
Revenue
34.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
101.50

Market Cap Chart

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 12.45B, an increase of 40.37%. That is a compound annual growth rate of 4.07%.

History

DateMarket Cap% Change
Aug 11, 202512.45B-13.38%
Dec 31, 202414.37B-31.28%
Dec 29, 202320.91B-42.13%
Dec 30, 202236.13B16.16%
Dec 30, 202131.10B17.15%
Dec 31, 202026.55B222.07%
Dec 31, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Feb 8, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition